We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+11.11%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$41.1B
AUM Growth
+$5.37B
Cap. Flow
+$2.44B
Cap. Flow %
5.94%
Top 10 Hldgs %
24.49%
Holding
1,526
New
158
Increased
755
Reduced
338
Closed
110

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$170M
2
TSLA icon
Tesla
TSLA
+$155M
3
NVDA icon
NVIDIA
NVDA
+$116M
4
TSM icon
TSMC
TSM
+$87.6M
5
NTR icon
Nutrien
NTR
+$86.2M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$150M
2
NOC icon
Northrop Grumman
NOC
+$112M
3
HON icon
Honeywell
HON
+$98.1M
4
LIN icon
Linde
LIN
+$87M
5
UBER icon
Uber
UBER
+$72.9M

Sector Composition

Rank Sector Weight
1 Technology 27.6%
2 Healthcare 16.16%
3 Financials 10.71%
4 Consumer Discretionary 9.79%
5 Communication Services 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALK icon
1401
Alaska Air
ALK
$5.45B
$21K ﹤0.01%
412
NCLH icon
1402
Norwegian Cruise Line
NCLH
$8.62B
$20K ﹤0.01%
918
LEN.B icon
1403
Lennar Class B
LEN.B
$20.2B
$19K ﹤0.01%
206
RL icon
1404
Ralph Lauren
RL
$23.9B
$19K ﹤0.01%
160
RITM icon
1405
Rithm Capital
RITM
$5.71B
$18K ﹤0.01%
+1,660
New +$18.5K
VIV icon
1406
Telefônica Brasil
VIV
$18.9B
$17K ﹤0.01%
2,000
CHRD icon
1407
Chord Energy
CHRD
$7.56B
$15K ﹤0.01%
+115
New +$13.7K
RDFN
1408
DELISTED
Redfin
RDFN
$13K ﹤0.01%
355
-2,502
-88% -$114K
UAA icon
1409
Under Armour
UAA
$2.35B
$13K ﹤0.01%
628
UA icon
1410
Under Armour Class C
UA
$2.29B
$12K ﹤0.01%
648
ALLK
1411
DELISTED
Allakos
ALLK
$11K ﹤0.01%
1,120
-16,670
-94% -$1.37M
NWS icon
1412
News Corp Class B
NWS
$17.7B
$9K ﹤0.01%
405
RGA icon
1413
Reinsurance Group of America
RGA
$16B
$9K ﹤0.01%
84
-2,584
-97% -$287K
XP icon
1414
XP
XP
$8.27B
$3K ﹤0.01%
+96
New +$3.13K
BNT
1415
Brookfield Wealth Solutions
BNT
$12.5B
$2K ﹤0.01%
42
-4,427
-99% -$178K
ACIU icon
1416
AC Immune
ACIU
$246M
-27,000
Closed -$182K
ADAP
1417
DELISTED
Adaptimmune Therapeutics
ADAP
-42,000
Closed -$215K
AFMD
1418
DELISTED
Affimed
AFMD
-10,000
Closed -$585K
AKBA icon
1419
Akebia Therapeutics
AKBA
$240M
-102,100
Closed -$293K
ALT icon
1420
Altimmune
ALT
$587M
-50,000
Closed -$626K
ANIP icon
1421
ANI Pharmaceuticals
ANIP
$1.73B
-3,450
Closed -$115K
ANNX icon
1422
Annexon
ANNX
$847M
-12,000
Closed -$217K
AVDL
1423
DELISTED
Avadel Pharmaceuticals
AVDL
-20,000
Closed -$194K
BHP icon
1424
BHP
BHP
$231B
-4,282
Closed -$202K
BIPC icon
1425
Brookfield Infrastructure
BIPC
$4.86B
-5,892
Closed -$235K

Similar funds

DekaBank Deutsche Girozentrale's Q4 2021 Portfolio in Review

As of Q4 2021, DekaBank Deutsche Girozentrale held 1,526 positions worth $41.1B, up 15% from $35.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

DekaBank Deutsche Girozentrale deployed $2.44B of net new capital in Q4 2021, opening 158 new positions and adding to 755 existing holdings. Its largest new stake was Regal Rexnord: 103,299 shares worth $17.6M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Visa, an estimated $150M trimmed.

  • DekaBank Deutsche Girozentrale's largest Q4 2021 buy was Regal Rexnord: 103,299 shares worth $17.6M.
  • DekaBank Deutsche Girozentrale added most to Mastercard in Q4 2021, an estimated $170M increase.
  • DekaBank Deutsche Girozentrale's biggest Q4 2021 reduction was Visa, cutting an estimated $150M.
  • DekaBank Deutsche Girozentrale fully exited Kansas City Southern in Q4 2021, selling an estimated $20.2M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 24% of its $41.1B portfolio in Q4 2021.
  • DekaBank Deutsche Girozentrale opened 158 new positions and closed 110 in Q4 2021.
  • DekaBank Deutsche Girozentrale's portfolio value rose 15% quarter-over-quarter to $41.1B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.